The clinical spectrum of the anti-phospholipid syndrome (APS) is not limited to vascular
thrombosis or miscarriages but includes additional manifestations that cannot be explained …

The antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized,
according to the Sydney criteria, by the persistent presence of autoantibodies directed …

Antiphospholipid antibody syndrome (APLS) is a rare autoimmune disease characterized by
recurrent arterial and venous thromboembolic events, pregnancy related complications as …

Hidroxicloroquina en el tratamiento de las enfermedades autoinmunes sistémicas SciELO -
Scientific Electronic Library Online vol.144 número2 Escenario actual y perspectivas de la …

Lupus anticoagulants (LACs) are associated with thromboembolic complications (TECs).
LACs can be detected by their anticoagulant properties in thrombin generation assays, by …

Introduction Antiphospholipid syndrome (APS) is associated with the risk of both arterial and
venous thrombosis. However, it is not known which factors might determine the location of …

Antiphospholipid syndrome (APS) is an adquired autoimmune pro-thrombotic disease
characterized by arterial and/or venous thrombosis and/or fetal losses associated with the …

Limited evidence exists to guide the management of recurrent thrombosis occurring despite
therapeutic anticoagulation in patients with thrombotic antiphospholipid syndrome (APS). In …

Systemic autoimmune diseases are conditions of unknown etiology, characterized by the
simultaneous or successive involvement of most organs and systems, as well as the …

Antiphospholipid syndrome (APS) is an auto-immune thrombophilia for which anti-
thrombotic medication is necessary for long-term management to reduce thrombotic risk or …